BIO

Jehoshua (Josh) Eliashberg is the Sebastian S. Kresge Professor of Marketing and Professor of Operations, Information and Decisions at the Wharton School of the University of Pennsylvania. He also held visiting scholar positions at the Business Schools of The University of Chicago, Chulalongkorn University (Bangkok, Thailand), Penn State University, INSEAD (Fontainebleau, France), Erasmus University (Rotterdam, The Netherlands), Singapore Management University, Carnegie-Mellon University, The University of British Columbia, UCLA, Time Inc., and at the Operations Research Department at AT&T Bell Laboratories. Professor Eliashberg received a B.Sc. in Electrical Engineering from the Technion-Israel Institute of Technology at Haifa, an M.B.A. from Tel-Aviv University, and a doctoral degree in Decision Sciences and Marketing from Indiana University. He also received an Honorary Masters from the University of Pennsylvania. Professor Eliashberg’s research interests are in developing models and methodologies to solve business problems. His research has focused on various issues including new product development and feasibility analysis, marketing/manufacturing/R&D interface, and competitive strategies. He has particular interest in the media and entertainment, pharmaceutical, and the hi-tech industries. He has authored numerous articles appearing in major academic journals. His work in the entertainment industry has been the subject of articles appearing in BusinessWeek, The Christian Science Monitor, The Financial Post, Financial Times, Forbes, Fortune, Los Angeles Times, The Philadelphia Inquirer, The New York Times, Variety, Newsweek, The Wall Street Journal, The Washington Post. He has co-edited the books, Handbooks in Operations Research and Management Science: Marketing (with G. L. Lilien) and Managing Business Interfaces: Marketing, Engineering, and Manufacturing Perspectives (with Amiya K. Chakravarty). Professor Eliashberg has held various editorial positions in leading professional journals including: the Marketing Departmental Editor in Management Science, an Editorial Board member for Marketing Science, the European Journal of Operational Research, Marketing Letter, and Senior Editor for Manufacturing and Service Operations Management. He is currently the Series Editor of Springer’s International Series in Quantitative Marketing and the Editor-in-Chief of Foundations and Trends in Marketing. He was elected a Fellow of the INFORMS Society for Marketing Science for his contributions to the field in June 2010 and was named a Fellow of The Institute for Operations Research and the Management Sciences in November 2010. He won the 2020 Gil Churchill Award which recognizes an individual’s contribution to marketing research including new methodologies, seminal publications, books, awards, and other notable contributions. His other professional services have included membership on the advisory boards of the National Science Foundation, the American Councils for International Education, and the academic liaison committee of the CMO Council. Professor Eliashberg has been teaching the following courses at Wharton: Marketing Research; Models for Marketing Strategy; New Product Management; Design, Manufacturing, and Marketing Integration; and Analysis of the Media and Entertainment Industries. Prior to joining academia, he was employed for a number of years as an electronic engineer and marketing. He has participated extensively in various executive education programs. His executive education and consulting activities include AccentHealth, AstraZeneca, AT&T, Booz, Allen & Hamilton, Bell Atlantic, Campbell Soup, Cheil Communications, CTV Television Network (Canada), Domino’s Pizza, Franklin Mint, General Motors, Givaudan, HBO, IBM, Independence Blue Cross, Inmar, Janssen Pharmaceutica Inc., Johnson & Johnson, L G Electronics, Lucent Technologies, Multimedia Development Corp. (Malaysia), Pathe Cinema (Holland), Philip Morris, The Siam Cement Group (Thailand), Sirius Satellite Radio, Warner Home Video, Weave Innovations Inc., Woodside Travel Trust, and Wyeth/Pfizer Pharmaceuticals.